Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 48.34 +0.80 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.54 | 52 Week High | $0.15 | |||
| Open | $48.44 | 52 Week Low | $0.15 | |||
| Day High | $49.46 | P/E | N/A | |||
| Day Low | $47.47 | EPS | $0.00 | |||
| Volume | 105,658 | |||||
